Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab

Clinical Rheumatology

Volumn 28, Issue 8, 2009, Pages 985-988

  Katsicas, María M ^a   Russo, Ricardo A G ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

Adalimumab; Etanercept; Infliximab; Juvenile idiopathic arthritis

Indexed keywords

ADALIMUMAB; CYCLOSPORIN; ETANERCEPT; IMMUNOGLOBULIN; INFLIXIMAB; MEPREDNISONE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CONTROL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FUNCTIONAL STATUS; HUMAN; JOINT LIMITATION; JOINT SWELLING; JUVENILE RHEUMATOID ARTHRITIS; MALE; OUTCOME ASSESSMENT; POLYARTHRITIS; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD; TREATMENT DURATION; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT FAILURE;

EID: 67849088698     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1162-7     Document Type: Article

References (15)

1. Schneider R, Passo MH (2002) Juvenile rheumatoid arthritis. Rheum Dis Clin North Am 28:503-530
2. De Benedetti F, Ravelli A, Martini A (1997) Cytokines in juvenile rheumatoid arthritis. Curr Opin Rheumatol 9:428-433
3. Wilkinson N, Jackson G, Gardner-Medwin J (2003) Biologic therapies for juvenile arthritis. Arch Dis Child 88:168-191
4. Ruperto N, Murray K, Gerloni V, Wulffraat N, Oliveira S, Falcini F et al (2004) A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who fail to response to standard doses of methotrexate. Arthritis Rheum 50:2191-2201
5. Lovell DJ, Reiff A, Jones OY, Schneider R, Nocton J, Stein L et al (2006) Long term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 54:1987-1994
6. Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M et al (2003) Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 48:1093-1101
7. Lahdenne P, Váhásalo P, Honkanen V (2003) Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: An open label study. Ann Rheum Dis 62:245-247
8. Favalli E, Arreghini M, Arnoldi C, Panni B, Marchesoni A, Tossi S et al (2004) Anti-tumor necrosis factor α switching in rheumatoid arthritis and juvenile chronic arthritis. Arthritis Rheum 51:299-304
9. Scallon B, Cai A, Solowski N, Rosenberg A, Song XY, Shealy D, Wagner C (2002) Binding and functional comparisons of two types of tumor necrosis factor antagonists. J Pharmacol Exp Ther 301:418-426
10. Moroldo MB, DeCunto C, Hubscher O, Liberatore D, Palermo R, Russo R et al (1998) Cross-cultural adaptation and validation of an Argentine-Spanish version of the Stanford Childhood Health Assessment Questionnaire (CHAQ). Arthritis Care Res 11:382-390
11. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A (1997) Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 40:1202-1209
12. Wallace CA, Huang B, Bandeira M, Ravelli A, Giannini EH (2005) Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum 52:3554-3562
13. Lovell D, Giannini E, Reiff A, Cawkwell G, Silverman ED, Nocton JJ et al (2000) Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 342:763-769
14. Katsicas MM, Russo RA (2005) Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept. Clin Exp Rheumatol 23:545-548
15. Lovell D, Ruperto N, Goodman S, Reiff A, Jung L, Jarosova K, Nemcová D, Mouy R et al (2008) Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med 359:810-820